isonaringin and Inflammation

isonaringin has been researched along with Inflammation* in 3 studies

Other Studies

3 other study(ies) available for isonaringin and Inflammation

ArticleYear
Narirutin exerts anti-inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:4

    Citrus peel has long been used in traditional medicine in Asia to treat common cold, dyspepsia, cough, and phlegm. Narirutin-a flavanone-7-O-glycoside-is the major flavonoid in citrus peel, and has anti-oxidative, anti-allergic, and anti-inflammatory activities. However, the anti-inflammatory mechanism of narirutin has not been fully elucidated. This study is aimed to investigate the effects of narirutin on the Nod-like receptor protein 3 (NLRP3)-mediated inflammatory response in vitro and in vivo, and determine the underlying mechanism. THP-1 differentiated macrophages and bone marrow-derived macrophages (BMDMs) were used for in vitro experiments, while dextran sulfate sodium (DSS)-induced colitis and alum-induced peritonitis mouse models were constructed to test inflammation in vivo. Narirutin suppressed secretion of interleukin (IL)-1β and pyroptosis in lipopolysaccharide (LPS)/ATP-stimulated macrophages. Narirutin decreased the expression of NLRP3 and IL-1β in the LPS-priming step through inhibition of NF-κB, MAPK and PI3K /AKT signaling pathways. Narirutin inhibited NLRP3-ASC interaction to suppress NLRP3 inflammasome assembly. Furthermore, oral administration of narirutin (300 mg/kg) alleviated inflammation symptoms in mice with peritonitis and colitis. These results suggest that narirutin exerts its anti-inflammatory activity by suppressing NLRP3 inflammasome activation via inhibition of the NLRP3 inflammasome priming processes and NLRP3-ASC interaction in macrophages.

    Topics: Animals; Anti-Inflammatory Agents; Colitis; Flavanones; Inflammasomes; Inflammation; Lipopolysaccharides; Macrophages; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Peritonitis

2023
Maternal Flavonoids Intake Reverts Depression-Like Behaviour in Rat Female Offspring.
    Nutrients, 2019, Mar-07, Volume: 11, Issue:3

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Diet; Disaccharides; Drug Interactions; Female; Flavanones; Flavonoids; Imipramine; Inflammation; Kaempferols; Male; Maternal Nutritional Physiological Phenomena; Monosaccharides; Pregnancy; Prenatal Exposure Delayed Effects; Protein Serine-Threonine Kinases; Rats; Rats, Wistar

2019
Narirutin inhibits airway inflammation in an allergic mouse model.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:8

    1. Flavonoids are naturally occurring compounds that possess anti-allergic, anti-inflammatory, antiproliferative and anti-oxidant properties. In the present study, we investigated whether the flavonoid narirutin could reduce airway inflammation in ovalbumin (OVA)-sensitized/challenged NC/Nga mice, a model of allergic eosinophilic airway inflammation. 2. Mice were initially immunized intraperitoneally with OVA on Days 0 and 7 and then challenged with inhaled OVA on Days 14, 15 and 16. In addition, some mice received narirutin orally at doses of 0.1, 1 or 10 mg/kg bodyweight daily on Days 7-16. 3. At 10 mg/kg, but not 0.1 or 1 mg/kg, narirutin significantly diminished OVA-induced airway inflammation caused by infiltration of lung tissue with inflammatory and mucus-producing cells, as well as reduced eosinophil counts in the peripheral blood and bronchoalveolar lavage fluid (BALF), interleukin (IL)-4 levels in BALF and IgE levels in serum. 4. The mechanism of the anti-inflammatory effect of narirutin are likely to be associated with a reduction in the OVA-induced increases of IL-4 and IgE in a murine model of allergic eosinophilic airway inflammation. These findings suggest that narirutin may be an effective new tool in the treatment of bronchial asthma.

    Topics: Aluminum Hydroxide; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Disaccharides; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Female; Flavanones; Immunoglobulin E; Inflammation; Interleukin-4; Interleukin-5; Leukocyte Count; Lung; Mice; Ovalbumin; Pulmonary Eosinophilia

2007